anonymous
Guest
anonymous
Guest
I’m all for D&I and I 100 percent agree with the principle of having it as part of our expectations. When I scroll through LinkedIn and Twitter all news related to Genentech is about diversity and equity. Great! But hardly anything about our molecules, indications, or significant approvals. when i scroll through other pharma postings, i read about their scientific progress, and how their science is changing patient outcomes. When they do report their D&I efforts I see highlights on real people and cases, not news stories about their D&I staff congratulating each other. Can we start informing the world about our science again? It’s making me think “do we even have discoveries and scientific progress we are excited about any more?”